Navigation Links
Cephalon Submits New Drug Application for TREANDA for the Treatment of Patients with Relapsed Indolent Non-Hodgkin's Lymphoma
Date:12/31/2007

ope, Cephalon markets three additional oncology products in 19 countries.

About Cephalon, Inc.

Cephalon, Inc. is an international biopharmaceutical company, recently inducted into the World Economic Forum Community of Global Growth Companies. For 20 years, the company has been dedicated to the discovery, development and commercialization of innovative products in four core therapeutic areas: central nervous system, pain, oncology and addiction. A member of the Fortune 1000, Cephalon currently employs approximately 3,000 people in the United States and Europe. U.S. sites include the company's headquarters in Frazer, Pennsylvania, and offices, laboratories or manufacturing facilities in West Chester, Pennsylvania, Salt Lake City, Utah, and suburban Minneapolis, Minnesota. Cephalon's European headquarters are located in Maisons-Alfort, France.

The company's proprietary products in the United States include: PROVIGIL(R) (modafinil) Tablets [C-IV], FENTORA(R) (fentanyl buccal tablet) [C-II], TRISENOX, AMRIX(TM) (cyclobenzaprine hydrochloride extended-release capsules), VIVITROL(R) (naltrexone for extended-release injectable suspension), GABITRIL(R) (tiagabine hydrochloride), NUVIGIL(TM) (armodafinil) Tablets [C-IV] and ACTIQ(R) (oral transmucosal fentanyl citrate) [C-II]. The company also markets numerous products internationally. Full prescribing information on its U.S. products is available at http://www.cephalon.com or by calling 1-800-896-5855.

In addition to historical facts or statements of current condition, this press release may contain forward-looking statements. Forward-looking statements provide Cephalon's current expectations or forecasts of future events. These may include statements regarding anticipated scientific progress on its research programs; development of potential pharmaceutical products, including the results of any clinical programs with respect to TREANDA or the ti
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Cephalon, Inc. Announces Agreement to Acquire AMRIX, A Once-Daily Extended-Release Muscle Relaxant
3. Cephalon Reinforces Important Prescribing and Dosing Information for FENTORA
4. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
5. Cephalon Quarterly Conference Call Invitation
6. Cephalon Announces Strong Third Quarter Financial Results
7. Cephalon Submits Supplemental New Drug Application for FENTORA
8. Exelixis Submits XL880 Diligence Report to GlaxoSmithKline
9. CV Therapeutics Submits Supplemental New Drug Application for Ranexa(R) (ranolazine extended-release tablets)
10. AMDL Submits Data to FDA for Clearance to Market Its DR-70(R) Diagnostic Test to Monitor Colorectal Cancer Patients
11. Angiotech Submits 510(K) To FDA For Its Innovative 5-FU CVC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2008)...RG, Md., Dec. 4 MedImmune today an...trial in patients with chronic asthma to,determin... monoclonal antibody,(MAb) that targets the inter...st that inhibiting the IL-5R pathway may lead to a...hma, supporting continued study of this antibody. ...
(Date:12/4/2008)...cember 4 Azur Pharma Limited ("Azu...finitive agreement with BioSante,Pharmaceuticals,... rights to,Elestrin(TM). Elestrin is a fast dryin... for the treatment of moderate to severe vasomotor... approved by the U.S. Food and Drug,Administratio...
(Date:12/4/2008)...any Introduces New Trade Name Onrigin(TM) for Laro...swire-FirstCall/ -- VION PHARMACEUTICALS, INC. (O...ncements related to events in connection with the ... at the Moscone Center in San Francisco from Decem...tion , , The Company announced that it wo...
(Date:12/4/2008)...C., Dec. 4 Parion Sciences, Inc. t...(Nasdaq: GILD ), has initiated a Phase I,clinic...te the safety and,tolerability of the investigati...rway hydration for the treatment of pulmonary dise...thelial sodium channel (ENaC) blocker discovered b...
Breaking Biology Technology:MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 2MedImmune Advances Asthma Program With Start of Phase 2 Clinical Trial for Antibody Targeting IL-5 Receptor 3Azur Pharma Ltd. Enters Into Definitive Agreement With BioSante Pharmaceuticals Inc [nasdaq: BPAX], to Acquire U.S. Rights to Elestrin (TM) 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 2Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 3Vion Pharmaceuticals to Present Survival Data on Laromustine at ASH Annual Meeting 4Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 2Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411 3
... Wisconsin undergrads are going to vie for a piece... creative inventions that could turn into business...ity and Tong Prototype Prize reward students for e...riculum. At this year,s Innovation Days, undergrad...ring Centers Building, 1550 Engineering Drive. , ,...
...cessfully imaged a piece of silicon just 10 nanome...she and her UW-Madison co-researchers were puzzled...ld be impossible because her microscopy method req...she did it, we realized, ,Hey, this silicon layer ...normally use," says UW-Madison physicist Mark Eri...
...nsin-Madison,s undergrad engineering contest was s...r energy collector that concentrates the sun,s ray...r won first place last Friday in both the Schoofs ... winning $12,500. , ,Instead of the mirrors that m...ranzke used a flat Fresnel lens to concentrate a l...
...at the DEMO conference, February 6-8: , ,Each DEM... this personal technology industry. Indeed, over t...s and more recently ups again. We,ve seen moments...rah of the Internet bubble at DEMO 2000. We,ve see...s, like the first web application servers and the ...
Other Biology Technology:Study explains unexpected conductivity of nanoscale silicon 2Study explains unexpected conductivity of nanoscale silicon 3Concentrated solar energy project wins Innovation Days prizes 2Consumer, business technologies face same challenges 2Consumer, business technologies face same challenges 3Consumer, business technologies face same challenges 4Consumer, business technologies face same challenges 5
(Date:12/4/2008)...INIA KEY, Fla. -- If you,re looking for bonefish f...about 321,000 to choose from, and that is down sli...due to increased participation among those who are...f Miami,s Rosenstiel School of Marine and Atmosphe...efish census, in conjunction with the conservation...
(Date:12/4/2008)...reat earthquakes and destructive tsunamis over the... of another large earthquake, warns an internation...published in the Dec. 4 issue of the journal Natu..., a magnitude 9.2 in December 2004, produced the m...emory. The cause of that calamity was the rupture...
(Date:12/3/2008)...d H. Jones, deputy executive director of the Inter...ergy Outlook 2008" Dec. 9 at Rice University,s Bak...ress such questions as: Is the world facing a supp...ent? What type of post-Kyoto policy framework migh...levels, and what impact might such a policy framew...
(Date:12/3/2008)...VILLE, Fla. The wild pea pod is big and heavy, wi...f its parent plant. , And yet, like a grounded t...t manages if it has a reasonable chance of escape... the world,s largest experimental landscape devote... or other natural areas have discovered the pea a...
Breaking Biology News(10 mins):Bonefish census reveals population holding steady 2September 2007 Sumatran earthquakes research findings 2September 2007 Sumatran earthquakes research findings 3'World Energy Outlook' to be presented at Rice University Dec. 9 2Rooted plants move mysteriously down greenways, scientists say 2Rooted plants move mysteriously down greenways, scientists say 3Deprived of a sense of smell worms live longer 5555 1Deprived of a sense of smell worms live longer 5555 2Monogram Announces Conference Call 8543 1Monogram Announces Conference Call 8543 2Local Research Foundation Achieves Milestone in Fight Against Cancer 3330 1Local Research Foundation Achieves Milestone in Fight Against Cancer 3330 2Local Research Foundation Achieves Milestone in Fight Against Cancer 3330 3Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday November 6 2008 After Close of U S Based Financial Markets 27684 1Nektar to Announce Financial Results for the Third Quarter of 2008 on Thursday November 6 2008 After Close of U S Based Financial Markets 27684 2
... oneself" in an activity--whether a movie, sport, ...he brain in the act of losing "self" as it shuts d... , The researchers--led by Rafael Malach and Ilan...orting in the April 20, 2006, issue of Neuron--say...tually shuts down during such intense sensory task...
...y Institute for Biotechnology (VIB) connected to t...t the quantity of amyloid protein in brain cells i...loid protein has already been known to be the prim...of patients. The new discovery demonstrates that t...duced, the younger the dementia patient is. , Al...
...y Institute for Biotechnology (VIB) connected to t...t the quantity of amyloid protein in brain cells i...loid protein has already been known to be the prim...of patients. The new discovery demonstrates that t...duced, the younger the dementia patient is. , Al...
...ernal and child welfare in Africa may incur unexpe...e if they do not include a component of family pla...ty of Bristol into rural communities in Ethiopia. ...of Science: Medicine, is the first study to demons...pment intervention (in this case, a tapped water s...
Other Biology News:Watching the brain switch off 'self' 2The urban evolution lab 2Researchers discover a new genetic cause of Alzheimer's disease 2Ethiopian development raises birth rate 2
The sample holders for gels are used to hold gels in place in the multi-sample tray I, which is used with Molecular Imager FX imaging systems.
...ining method for labeling DNA breaks to detect apo...ll the key reagents required for measuring apoptos...ol cells for assessing reagent performance; washin...ividual steps in the assay; terminal deoxynucleoti...
Zero -mr agarose is specifically for electrofocusing. It has no detectable endoosmosis, and is recommended for electrofocusing of very high molecular weight proteins or complexes that are subject to
...000 system, 220-240 V, is used for nucleic acid se...at. The system includes the modular Sequi-Gen GT e...g nucleic acids with single base-pair resolution a...ly (IPC and bonded inner glass plate, outer glass ...
Biology Products: